- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Cohance Lifesciences paid a ₹8.30 Cr RBI compounding fee for a past forex violation. Operationally, the company made strides in FY26, reducing energy intensity by 16.9% and Scope 1&2 GHG by 18.9%. Zero Liquid Discharge is implemented at multiple units. Exports contribute 84% of turnover.